Health-related quality of life among prescription opioid-dependent patients: Results from a multi-site study

American Journal on Addictions

Volumn 24, Issue 4, 2015, Pages 308-314

  Griffin, Margaret L ^a,b   Bennett, Heather E ^a   Fitzmaurice, Garrett M ^a,c   Hill, Kevin P ^a,b   Provost, Scott E ^a   Weiss, Roger D ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; OPIATE; OPIATE AGONIST; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MULTICENTER STUDY; OPIATE ADDICTION; OUTCOME ASSESSMENT; PATIENT COUNSELING; POPULATION; PRESCRIPTION; PREVALENCE; PSYCHOLOGICAL WELL BEING; PSYCHOPHARMACOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SHORT FORM 36; SUBSTANCE ABUSE; SUBSTANCE USE; TREATMENT RESPONSE; AGED; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DRUG MISUSE; HEALTH SURVEY; MIDDLE AGED; OPIOID-RELATED DISORDERS; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; UNITED STATES; YOUNG ADULT;

ADULT; AGED; ANALGESICS, OPIOID; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE; QUALITY OF LIFE; UNITED STATES; YOUNG ADULT;

EID: 84928956746     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/ajad.12188     Document Type: Article

References (52)

1. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013.
2. Compton WM, Volkow ND,. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006;81:103-107.
3. Zacny J, Bigelow G, Compton P, et al. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. 2003;69:215-232.
4. Brands B, Blake J, Sproule B, et al. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend. 2004;73:199-207.
5. Moore BA, Fiellin DA, Barry DT, et al. Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients. J Gen Intern Med. 2007;22:527-530.
6. Nielsen S, Hillhouse M, Mooney L, et al. Comparing buprenorphine induction experience with heroin and prescription opioid users. J Subst Abuse Treat. 2012;43:285-290.
7. Sigmon SC,. Characterizing the emerging population of prescription opioid abusers. Am J Addict. 2006;15:208-212.
8. Kanwal F, Gralnek IM, Hays RD, et al. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol. 2009;7:793-799.
9. Bergman S, Jacobsson LT, Herrstrom P, et al. Health status as measured by SF-36 reflects changes and predicts outcome in chronic musculoskeletal pain: a 3-year follow up study in the general population. Pain. 2004;108:115-123.
10. Zahran HS, Kobau R, Moriarty DG, et al. Health-related quality of life surveillance-United States, 1993-2002. MMWR Surveill Summ. 2005;54:1-35.
11. Laudet AB,. The case for considering quality of life in addiction research and clinical practice. Addict Sci Clin Pract. 2011;6:44-55.
12. Garner BR, Scott CK, Dennis ML, et al. The relationship between recovery and health-related quality of life. J Subst Abuse Treat. 2014;47:293-298.
13. Karow A, Verthein U, Pukrop R, et al. Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence. Subst Use Misuse. 2011;46:705-715.
14. Pud D, Zlotnick C, Lawental E,. Pain depression and sleep disorders among methadone maintenance treatment patients. Addict Behav. 2012;37:1205-1210.
15. Morgan TJ, Morgenstern J, Blanchard KA, et al. Health-related quality of life for adults participating in outpatient substance abuse treatment. Am J Addict. 2003;12:198-210.
16. Smith KW, Larson MJ,. Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. Am J Drug Alcohol Abuse. 2003;29:323-335.
17. Stein MD, Mulvey KP, Plough A, et al. The functioning and well being of persons who seek treatment for drug and alcohol use. J Subst Abuse. 1998;10:75-84.
18. Astals M, Domingo-Salvany A, Buenaventura CC, et al. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Subst Use Misuse. 2008;43:612-632.
19. Deering D, Frampton C, Horn J, et al. Health status of clients receiving methadone maintenance treatment using the SF-36 health survey questionnaire. Drug Alcohol Rev. 2004;23:273-280.
20. Millson PE, Challacombe L, Villeneuve PJ, et al. Self-perceived health among Canadian opiate users: a comparison to the general population and to other chronic disease populations. Can J Public Health. 2004;95:99-103.
21. O'Brien S, Mattick RP, White J, et al. Maintenance pharmacotherapy for opioid dependence and SF-36 health status: a comparison with general population norms and other chronic disorders. Addict Disord Their Treat. 2006;5:155-164.
22. Rosen D, Smith ML, Reynolds CF, 3rd,. The prevalence of mental and physical health disorders among older methadone patients. Am J Geriatr Psychiatry. 2008;16:488-497.
23. Ryan CF, White JM,. Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction. 1996;91:39-45.
24. Cicero TJ, Surratt HL, Kurtz S, et al. Patterns of prescription opioid abuse and comorbidity in an aging treatment population. J Subst Abuse Treat. 2012;42:87-94.
25. Haug NA, Sorensen JL, Lollo ND, et al. Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial. AIDS Care. 2005;17:1022-1029.
26. Wu LT, Ling W, Burchett B, et al. Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: results from the National Drug Abuse Treatment Clinical Trials Network. Subst Abuse Rehabil. 2010;2010:13-22.
27. Millson P, Challacombe L, Villeneuve PJ, et al. Determinants of health-related quality of life of opiate users at entry to low-threshold methadone programs. Eur Addict Res. 2006;12:74-82.
28. Cicero TJ, Lynskey M, Todorov A, et al. Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain. 2008;139:127-135.
29. Tiffany ST, Friedman L, Greenfield SF, et al. Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction. 2012;107:709-718.
30. Weiss RD, Potter JS, Fiellin DA, et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011;68:1238-1246.
31. Fiellin DA, Pantalon MV, Chawarski MC, et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med. 2006;355:365-374.
32. Sigmon SC, Dunn KE, Badger GJ, et al. Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study. Addict Behav. 2009;34:304-311.
33. Arfken CL, Johanson CE, di Menza S, et al. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians. J. Subst. Abuse Treat. 2010;39:96-104.
34. Ware JE, Jr, Sherbourne CD,. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-483.
35. McHorney CA, Ware JE, Jr., Rogers W, et al. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care. 1992;30:MS253-MS265.
36. Ware JE, Jr., Kosinski M, Bjorner JB, et al. User's Manual for the SF-36v2 Health Survey. 2nd ed. Lincoln, RI: QualityMetric Incorporated 2007.
37. Robins LN, Wing J, Wittchen HU, et al. The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45:1069-1077.
38. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86:1119-1127.
39. McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9:199-213.
40. SPSS Statistics for Windows, Version 20.0 [computer program]. Armonk, NY: IBM Corp. 2011
41. Richter D, Eikelmann B, Berger K,. Use of the SF-36 in the evaluation of a drug detoxification program. Qual Life Res. 2004;13:907-914.
42. Garg N, Yates WR, Jones R, et al. Effect of gender, treatment site and psychiatric comorbidity on quality of life outcome in substance dependence. Am J Addict. 1999;8:44-54.
43. Gormsen L, Rosenberg R, Bach FW, et al. Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. Eur J Pain. 2010;14:e1-e8. 127
44. McWilliams LA, Cox BJ, Enns MW,. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain. 2003;106:127-133.
45. Weiss RD, Potter JS, Griffin ML, et al. Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain. J Subst Abuse Treat. 2014;47:140-145.
46. Laaksonen M, Rahkonen O, Martikainen P, et al. Smoking and SF-36 health functioning. Prev Med. 2006;42:206-209.
47. Sarna L, Bialous SA, Cooley ME, et al. Impact of smoking and smoking cessation on health-related quality of life in women in the Nurses' Health Study. Qual Life Res. 2008;17:1217-1227.
48. De Maeyer J, Vanderplasschen W, Broekaert E,. Quality of life among opiate-dependent individuals: A review of the literature. Int J Drug Policy. 2010;21:364-380.
49. Lopez-Bastida J, Linertova R, Oliva-Moreno J, et al. Social economic costs and health-related quality of life in patients with systemic sclerosis in Spain. Arthritis Care Res (Hoboken). 2014;66:473-480.
50. Stewart AL, Greenfield S, Hays RD, et al. Functional status,well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA. 1989;262:907-913.
51. Emery MP, Perrier LL, Acquadro C,. Patient-reported outcome and quality of life instruments database (PROQOLID): frequently asked questions. Health Qual Life Outcomes. 2005;3:12.
52. ∗D trial. Depress Anxiety. 2014;31:707-716.